Chitosan and its salts for mucosal and transmucosal delivery

被引:79
作者
Bonferoni, Maria Cristina [1 ]
Sandri, Giuseppina [1 ]
Rossi, Silvia [1 ]
Ferrari, Franca [1 ]
Caramella, Carla [1 ]
机构
[1] Univ Pavia, Dept Pharmaceut Chem, I-27100 Pavia, Italy
关键词
anti-infective properties; chitosan; ionic interaction; mucoadhesion; penetration enhancement; peptidase inhibition; wound healing; PEPTIDE DRUG-DELIVERY; IN-VITRO EVALUATION; MOLECULAR-WEIGHT; MUCOADHESIVE POLYMERS; PENETRATION ENHANCEMENT; ANTIMICROBIAL ACTIVITY; ABSORPTION ENHANCERS; NASAL ABSORPTION; ORAL DELIVERY; DERIVATIVES;
D O I
10.1517/17425240903114142
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
This review considers the application of chitosan and its salts in the delivery of drugs intended to act locally towards diseases of the mucosa itself (mucosal delivery), and to undergo systemic absorption by means of transmucosal routes (transmucosal delivery). Those chitosan properties that are particularly useful in mucosal and transmucosal delivery have been reviewed, such as mucoadhesion, penetration enhancement and peptidase inhibition behaviour. Chitosan bioactive properties have also been considered, such as anti-infective, haemostatic, wound healing and immune-stimulating activity. Chitosan is available with a wide range of molecular mass and deacetylation degree: the influence of these properties on polymer performance and solubility has been taken into account. As solubility in particular can strongly limit the results obtained at pH values close to neutrality, particular attention has been paid to chitosan salts and derivatives with modified solubility. Thanks to the presence of positively charged amino groups of the polymer, a subject of increasing interest is the exploitation of its interaction with acidic molecules having potential synergistic behaviour towards bioactive properties, or even with acidic drugs. The aim of the review is to describe not only some properties of chitosan, but also the way they can be modified by the acidic moiety.
引用
收藏
页码:923 / 939
页数:17
相关论文
共 122 条
[1]
Recent advances on chitosan-based micro- and nanoparticles in drug delivery [J].
Agnihotri, SA ;
Mallikarjuna, NN ;
Aminabhavi, TM .
JOURNAL OF CONTROLLED RELEASE, 2004, 100 (01) :5-28
[2]
Chitosan delivery systems for the treatment of oral mucositis:: in vitro and in vivo studies [J].
Aksungur, P ;
Sungur, A ;
Ünal, S ;
Iskit, AB ;
Squier, CA ;
Senel, S .
JOURNAL OF CONTROLLED RELEASE, 2004, 98 (02) :269-279
[3]
ALONSO FMJ, 1997, Patent No. 0771566
[4]
Mucoadhesive polymeric platforms for controlled drug delivery [J].
Andrews, Gavin P. ;
Laverty, Thomas P. ;
Jones, David S. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2009, 71 (03) :505-518
[5]
HYDROGEN-ION TITRATION OF CHITOSANS WITH VARYING DEGREES OF N-ACETYLATION BY MONITORING INDUCED H-1-NMR CHEMICAL-SHIFTS [J].
ANTHONSEN, MW ;
SMIDSROD, O .
CARBOHYDRATE POLYMERS, 1995, 26 (04) :303-305
[6]
Chitosan-based systems for the delivery of vaccine antigens [J].
Arca, H. Cigdem ;
Guenbeyaz, Merve ;
Senel, Sevda .
EXPERT REVIEW OF VACCINES, 2009, 8 (07) :937-953
[7]
Chitosan as a nasal delivery system: Evaluation of insulin absorption enhancement and effect on nasal membrane integrity using rat models [J].
Aspden, TJ ;
Illum, L ;
Skaugrud, O .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 4 (01) :23-31
[8]
*ASTM, 2007, F210301 ASTM
[9]
Optimized synthesis and characterization of N-triethyl chitosan [J].
Avadi, MR ;
Zohuriaan-Mehr, MJ ;
Younessi, P ;
Amini, M ;
Tehrani, MR ;
Shafiee, A .
JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS, 2003, 18 (06) :469-479
[10]
N,N-diethyl N-methyl chitosan as an enhancing agent for colon drug delivery [J].
Avadi, MR ;
Erfan, M ;
Sadeghi, AMM ;
Moezi, L ;
Dehpour, AR ;
Younessi, P ;
Tehrani, MR ;
Shafiee, A .
JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS, 2004, 19 (05) :421-433